Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
American Journal of Hematology
|
March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Anticancer Research
|
September 29, 2020
Impact of the Affordable Care Act on Timeliness to Treatment for Patients With Multiple Myeloma
Thejus Jayakrishnan, Veli Bakalov, Natalie S Callander, et al.
Blood
|
February 1, 2003
AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma
Sun J Choi, Tomoko Oba, Natalie S Callander, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 26, 2020
Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?
Olivia M Kim, Jason R Jared, Emily R Hennes, et al.
Plos One
|
December 8, 2022
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs
Mailee Huynh, Hae Yeun Chang, Dominique N Lisiero, et al.
Endocrinology
|
September 11, 2019
Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity
David K Lung, Jay W Warrick, Peiman Hematti, et al.
Blood
|
July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma
A Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Blood
|
January 21, 2012
Microscale functional cytomics for studying hematologic cancers
Edmond W K Young, Chorom Pak, Brad S Kahl, et al.
Transplantation and Cellular Therapy
|
November 15, 2023
PD1<sup>+</sup>TIGIT<sup>+</sup>2B4<sup>+</sup>KLRG1<sup>+</sup> Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy
Ameet K Mishra, Timothy M Schmidt, Ella B Martell, et al.
Integrative Cancer Science and Therapeutics
|
December 14, 2019
Reduction in oral mucositis severity using a topical vasoconstrictor: A case report of three bone marrow transplant patients
Amanda Graul-Conroy, Margo Hoover-Regan, Kenneth B DeSantes, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
American Journal of Hematology
|
March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Anticancer Research
|
September 29, 2020
Impact of the Affordable Care Act on Timeliness to Treatment for Patients With Multiple Myeloma
Thejus Jayakrishnan, Veli Bakalov, Natalie S Callander, et al.
Blood
|
February 1, 2003
AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma
Sun J Choi, Tomoko Oba, Natalie S Callander, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 26, 2020
Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?
Olivia M Kim, Jason R Jared, Emily R Hennes, et al.
Plos One
|
December 8, 2022
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs
Mailee Huynh, Hae Yeun Chang, Dominique N Lisiero, et al.
Endocrinology
|
September 11, 2019
Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity
David K Lung, Jay W Warrick, Peiman Hematti, et al.
Blood
|
July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma
A Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Blood
|
January 21, 2012
Microscale functional cytomics for studying hematologic cancers
Edmond W K Young, Chorom Pak, Brad S Kahl, et al.
Transplantation and Cellular Therapy
|
November 15, 2023
PD1<sup>+</sup>TIGIT<sup>+</sup>2B4<sup>+</sup>KLRG1<sup>+</sup> Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy
Ameet K Mishra, Timothy M Schmidt, Ella B Martell, et al.
Integrative Cancer Science and Therapeutics
|
December 14, 2019
Reduction in oral mucositis severity using a topical vasoconstrictor: A case report of three bone marrow transplant patients
Amanda Graul-Conroy, Margo Hoover-Regan, Kenneth B DeSantes, et al.
Page
of 10